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The -secretase complex represents an evolutionarily con-
served family of transmembrane aspartyl proteases that 
cleave numerous type-I membrane proteins, including the -
amyloid precursor protein (APP) and the receptor Notch. All 
known rare mutations in APP and the -secretase catalytic 
component, presenilin, which lead to increased amyloid -
peptide production, are responsible for early-onset familial 
Alzheimer’s disease. -amyloid protein precursor-like (APPL) is 
the Drosophila ortholog of human APP. Here, we created 
Notch- and APPL-based Drosophila reporter systems for in 
vivo monitoring of -secretase activity. Ectopic expression of 
the Notch- and APPL-based chimeric reporters in wings re-
sults in vein truncation phenotypes. Reporter-mediated vein 
truncation phenotypes are enhanced by the Notch gain-of-
function allele and suppressed by RNAi-mediated knockdown 
of presenilin. Furthermore, we find that apoptosis partly con-
tributes to the vein truncation phenotypes of the APPL-based 
reporter, but not to the vein truncation phenotypes of the 
Notch-based reporter. Taken together, these results suggest 
that both in vivo reporter systems provide a powerful genetic 
tool to identify genes that modulate -secretase activity 
and/or APPL metabolism. 
 
Keywords: -secretase, Alzheimer’s disease, APPL, Notch, 
presenilin 
 
INTRODUCTION 
 
The -secretase complex, which consists of at least four pro-
teins-Presenilin (PS), Nicastrin, Aph-1, and Pen-2, serves as a 
transmembrane aspartyl protease that plays a critical role in 
Alzheimer’s disease (AD) and Notch signaling pathway (Bai 
et al., 2015; De Strooper, 2003; Fortini, 2009). Amyloid -
peptides (As), which are the main constituents of senile 
plaques present in the brain affected with AD, are generated 
by sequential cleavages of the -amyloid precursor protein 
(APP) by -secretase (BACE) and -secretase (Esler and 
Wolfe, 2001; Goedert, 2015). Another well-known sub-
strate for -secretase is Notch, whose signaling controls a 
large number of cell fate decisions during development 
(Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006). The 
cleavage of both APP and Notch within their single-pass 
transmembrane domains by -secretase releases cytosolic 
fragments and allows them to enter the nucleus, thereby 
regulating gene transcription (Brown et al., 2000; Cao and 
Südhof, 2001; Louvi and Artavanis-Tsakonas, 2006; Wang et 
al., 2014; Figs. 1A and 1B). This -secretase-dependent regu-
lated intramembrane proteolysis (RIP) is tightly controlled 
(Brown et al., 2000), and thus alterations in the RIP of APP 
and Notch result in developmental defects and diseases (Es-
ler and Wolfe, 2001; Louvi and Artavanis-Tsakonas, 2006). 
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AD is the most common form of senile dementia charac-
terized by the deposition of aggregation-prone As and 
neurofibrillary tangles in the brain (Selkoe, 1998). Interest-
ingly, early-onset familial Alzheimer’s disease (EOAD) is 
caused by rare mutations in APP, PS1, and PS2 (Tanzi, 2012). 
This is consistent with the fact that PS is the catalytic subunit 
of the -secretase complex whereas APP is a substrate for -
secretase (De Strooper, 2003). In addition, -secretase activi-
ty and A production were not detected in PS1/PS2 double-
knockout cells (Herreman et al., 2000; Zhang et al., 2000). 
Therefore, -secretase serves as a therapeutic target to re-
duce A production and development of -secretase inhibi-
tors can provide an effective therapy for AD. However, there 
is still one major concern that -secretase inhibitors might 
cause deleterious side effects because they also affect the 
RIP of numerous other substrates including Notch (Esler and 
Wolfe, 2001; McCarthy et al., 2009). One possible approach 
to overcome this problem is to identify new therapeutic tar-
get genes that specifically affect the -secretase-dependent 
processing of APP rather than other substrates. To this end, 
we built a Drosophila reporter system for in vivo detection of 
-secretase activity by taking advantage of the Notch signal-
ing pathway in the wing. 
Canonical Notch signaling, which is highly conserved in 
the animal kingdom, is initiated by the binding of ligands 
including Delta, Serrate, and LAG-2 (Fortini, 2009; Louvi and 
Artavanis-Tsakonas, 2006). Ligand binding induces sequen-
tial cleavages of the Notch receptor by ADAM family metal-
loproteases and -secretase, releasing the Notch intracellular 
domain (NICD) (Fortini, 2009; Louvi and Artavanis-Tsakonas, 
2006). NICD then enters the nucleus and forms an active 
transcriptional complex with the DNA-binding protein Sup-
pressor of Hairless (Su(H)) and Mastermind (MAM), trigger-
ing expression of Notch target genes (Fortini, 2009; Louvi 
and Artavanis-Tsakonas, 2006; Fig. 1B). In the absence of 
Notch signaling, Su(H) proteins associate with various core-
pressors to actively repress the transcription of Notch target 
genes (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006; 
Fig. 1B). These findings demonstrate that Su(H) is the key 
effector of Notch signaling. 
The Drosophila homolog of human APP is known as -
amyloid protein precursor-like (APPL) (Martin-Morris and 
White, 1990). Flies homozygous for Appl deletion allele 
showed a fast phototaxis defect that can be restored by 
human APP as well as fly APPL, revealing their functional 
conservation (Luo et al., 1992). Furthermore, APPL is proteo-
lytically cleaved by a BACE-like secretase (dBACE) and -
secretase, producing a neurotoxic A-like fragment in Dro-
sophila (Carmine-Simmen et al., 2009). However, dBACE 
does not appear to recognize and cleave human APP at the 
-secretase (BACE) cleavage site, suggesting the lack of a 
clear homolog of human BACE in Drosophila (Carmine-
Simmen et al., 2009; Greeve et al., 2004). In contrast, each 
component and the activity of the -secretase complex ap-
pear to be evolutionarily conserved across invertebrates and 
vertebrates (De Strooper, 2003; Selkoe and Wolfe, 2007). In 
support of this claim, Drosophila -secretase can cleave hu-
man APP and thus produce A peptides in combination with 
human BACE (Greeve et al., 2004). 
Here, we have created a Drosophila reporter system for in 
vivo monitoring of -secretase activity and it provides a genetic 
tool to discover novel genes that modulate -secretase-medi-
ated RIP of Notch and APP-like (APPL), and APPL metabolism. 
 
MATERIALS AND METHODS 
 
Drosophila strains 
The w1118 Drosophila strain was used as a wild-type control. 
The following flies were obtained from the Bloomington Stock 
Center: UAS-psn RNAi (#27681), UAS-p35 (#5073), UAS-psn 
(#8310), e16E-GAL4 (#30557), and NAx-E2 (#51660). The 
e16E-GAL4 enhancer trap line was shown to drive expression 
of a reporter gene in the striped pattern of engrailed during 
embryonic development (Weiss et al., 2001) and also in the 
posterior compartment of the wing imaginal disc during third 
instar larval stage (Johnson et al., 1995). 
 
Expression constructs 
The UAS-NTM-SV and UAS-APPL-SV constructs were gener-
ated by PCR and/or restriction enzyme-based strategies and 
subcloned into the pUAST vector (Brand and Perrimon, 
1993). For the Litmus 28-Su(H)-VP16 (SV), a NcoI-PstI frag-
ment from pGEX-Su(H) (Bailey and Posakony, 1995), which 
contains the DNA-binding domain (amino acids 109-457; 
GenBank: AAF53434.1) of Su(H), and a PstI-XbaI fragment 
from pAct-GAL4-VP16 (Han and Manley, 1993), which con-
tains the transcriptional activation domain (amino acids 2-
79; GenBank: AIZ65950.1) of VP16, were subcloned into 
the Litmus 28 vector (New England Biolabs, Inc.). For the 
Litmus 28-NTM-SV, a SalI-NcoI fragment from a Notch 
minigene clone (Wharton et al., 1985), which contains the 
NTM (amino acids 1710-1891; GenBank: AAF45848.2), and 
a BglII-SalI fragment from Litmus 28-NECN (Ju et al., 2000), 
which contains the signal peptide region (amino acids 1-60) 
of Notch, were subcloned into the Litmus 28-SV. For the 
UAS-NTM-SV, a BglII-XbaI fragment from the Litmus 28-NTM-
SV was subcloned into the pUAST vector. For the UAS-APPL-
SV construct, a EcoRI-NcoI fragment from GH04413, which 
encodes the full-length APPL (amino acids 1-887; GenBank: 
AAF45520), and a NcoI-XbaI fragment from the Limus 28-
SV, were subcloned into the pUAST vector. These construct 
sequences were confirmed by DNA sequencing. Transgenic 
flies carrying these constructs were created according to 
standard D. melanogaster transformation procedures (KAIST 
transgenic fly service). Multiple independent lines for the 
same transgenic construct are indicated by superscripts. For 
example, NTM-SV61f and NTM-SV42m are independent insertion 
lines for the construct UAS-NTM-SV. 
 
Immunohistochemistry 
Expression patterns of transgenes were visualized using anti-
VP16 monoclonal antibody (14-5, Santa Cruz Biotech.) and 
3,3'-diaminobenzidine reaction, as described previously 
(Jeong et al., 2012; Kim et al., 1995). 
 
Preparation of Drosophila wings and phenotypic 
characterization 
Using two pairs of forceps, the wings of female and male 
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adult flies (younger than 3 days) were carefully cut off and 
subsequently were arranged in the same orientation on a 
glass slide. A coverslip was applied and each corner of the 
coverslip was sealed with a regular nail polish. In wild-type 
wing, the average L4 to L3 vein length ratio was 0.97 and 
the average L5 to L3 vein length ratio was 0.58 (see Sup-
plementary Fig. S1A). The average percentages of L4 and L5 
vein truncations were calculated by the following equations 
(see Supplementary Fig. S1B): 
 
L4 vein truncation = [(0.97x-y)/(0.97x)] × 100 (%) 
L5 vein truncation = [(0.58x-z)/(0.58x)] × 100 (%) 
  x = L3 vein length 
  y = L4 vein length 
  z = L5 vein length 
 
Statistical analysis 
All quantitative data are presented as mean ± standard error 
of the mean (S.E.M.). Statistical significance was determined 
using unpaired t-test (*p < 0.05, **p < 0.01, and ***p < 
0.001). 
 
RESULTS 
 
Generation of transgenic reporters for in vivo detection of 
the processing of Notch and APPL 
We decided to take advantage of the Notch signaling path-
way to generate transgenic reporters for in vivo detection of 
the activity of -secretase, which acts as a key player in Alz-
heimer’s disease (AD) (Esler and Wolfe, 2001; Selkoe, 1998). 
Notch is cleaved within its single-pass transmembrane do-
main by -secretase (Fortini, 2009; Louvi and Artavanis-
Tsakonas, 2006). The cleavage of the Notch receptor releases 
its intracellular domain (NICD) and translocates it into the 
nucleus, thereby driving the expression of Notch target 
genes through the assembly of an active transcriptional 
complex with Su(H) and Mastermind (Fortini, 2009; Louvi 
and Artavanis-Tsakonas, 2006; Figs. 1A and 1B). Vein pat-
tern formation in the Drosophila wing is controlled by Notch 
signaling (de Cellis, 1998). Reduction in Notch signaling 
activity leads to the formation of thicker veins, whereas in-
creased Notch activity results in loss of veins (de Cellis and 
Garcia-Bellido, 1994a). These observations prompted us to 
examine whether Notch activity is correlated with vein phe-
notypes in a dose-dependent manner. Normal vein pattern-
ing was observed in wild-type females (Fig. 2A), whereas in 
females heterozygous for NAx-E2, a dominant gain-of-
function (GOF) Abruptex (Ax) allele (de Cellis and Garcia-
Bellido, 1994b), vein L5 consistently failed to reach the wing 
margin (5.4% L5 vein truncation; Figs. 2B and 2I). This Ax 
phenotype of vein L5 was significantly increased up to 
26.1% vein truncation in females homozygous for NAx-E2 (p 
= 0.002, t-test; Figs. 2C and 2I). In addition, these homozy-
gous mutants displayed a moderately truncated L4 vein 
(4.8% vein truncation; Figs. 2C and 2I). These findings sug-
gest that the severity of Ax vein phenotype is proportional to 
Notch signaling activity. To further address whether -
secretase activity is required for patterning of the Drosophila 
wing veins, we took advantage of the RNA interference 
A 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Generation of the Notch- and APPL-based Fusion Report-
ers. (A) Schematic diagram of the Notch- and APPL-based 
reporter transgenes. SP, signal peptide; EGF, epidermal 
growth factor-like; LNR, Lin12-Notch repeats; ANK, seven 
ankyrin repeat domains; NICD, Notch intracellular domain; 
Su(H)DB, the DNA-binding domain of Su(H); VP16AD, the 
transcriptional activation domain of the virus VP16; HBD, 
heparin-binding domain; CuBD, copper-binding domain; Ac, 
acidic domain; E2, APP extracellular carbohydrate domain. 
(B) Transcriptional switch in the Drosophila canonical Notch 
signaling pathway. In the absence of Notch signaling, Su(H) 
protein functions as a transcriptional repressor through re-
cruiting co-repressors (Co-R) including Hairless, Groucho 
and CtBP. Notch activation is triggered by ligand binding and 
sequential cleavages of ADAM family metalloproteases and 
-secretase. The second cleavage liberates the NICD, which 
then enters the nucleus and associates with Su(H) and Mas-
termind (MAM) to drive the transcription of Notch target 
genes. Co-A, co-activators. 
 
 
 
(RNAi) technique. When the Drosophila presenilin (psn) 
gene was knocked down by overexpression of psn RNAi 
transgene using e16E-GAL4, which is expressed in the pos-
terior compartment of the wing (Johnson et al., 1995), wing 
patterns showed robust vein thickening but no vein trunca-
tion phenotypes (Figs. 2D and 2I). This vein thickening phe-
notype, which is reminiscent of the phenotype found in 
Notch loss-of-function alleles (de Cellis and Garcia-Bellido, 
1994a), was completely restored by coexpression of wild- 
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Fig. 2. Wing vein phenotypes of Notch gain-of-function and pre-
senilin loss-of-function alleles. (A) Wild-type wing shows a 
normal pattern of five longitudinal veins (L1-L5). Scale bar 
indicates 50 m. (B) In females heterozygous for NAx-E2, the 
wing displays mild truncation only in L5 vein (arrow). (C) In 
females homozygous for NAx-E2, the wing displays mild trun-
cation in L4 vein and moderate truncation in L5 vein (ar-
rows). (D) Overexpression of psn RNAi in the posterior com-
partment results in vein thickening (square brackets in blue). 
(E) Female wing overexpressing wild-type Psn shows a nor-
mal vein pattern. (F) Overexpression of wild-type Psn com-
pletely rescues the psn RNAi-induced vein thickening pheno-
type. (G) In males hemizygous for NAx-E2, the wing exhibits 
mild truncation in L4 vein and moderate truncation in L5 
vein (arrows). (H) Vein truncation phenotype observed in 
NAx-E2 hemizygotes is suppressed by RNAi-mediated knock-
down of psn. Square brackets indicate vein thickening phe-
notype.(I) Percentages of wing vein truncations in females 
and males with indicated genotypes (**p < 0.01 and ***p < 
0.001, t-test). Error bars indicate S.E.M. by t-test. n = num-
ber of wings scored for each genotype. 
 
 
 
type Psn (Fig. 2F). Overexpression of wild-type Psn alone 
hardly affected vein patterning (Figs. 2E and 2I). These re-
sults indicate target gene specificity of the psn RNAi 
transgene. Furthermore, knockdown of psn in the posterior 
compartment using e16E-GAL4 completely suppressed the 
vein truncation phenotype observed in males hemizygous for 
NAx-E2 (Figs. 2G and 2H). Taken together, these findings 
strongly suggest that -secretase activity contributes to vein 
pattern formation in the Drosophila wing through the Notch 
signaling pathway. 
To monitor the proteolytic cleavage of Notch and APPL by 
-secretase within their transmembrane domains, we ex-
plored a sensitive reporter system, in which the chimeric 
transcriptional activator Su(H)-VP16 (SV) is fused to either a 
subfragment of Notch (NTM) or full-length APPL (UAS-NTM-
SV and UAS-APPL-SV in Fig. 1A). The NTM subfragment pos-
sesses a transmembrane domain and the N-terminal region 
of NICD (Fig. 1A). The SV was created by fusion of the DNA-
binding domain of Su(H) transcription factor (Bailey and 
Posakony, 1995) and the transcriptional activation domain 
of the virus VP16 (Sadowski et al., 1988) (Fig. 1A). Therefore, 
in case of nuclear translocation of the SV proteins, they are 
supposed to activate some of the Notch target genes, mim-
icking increased Notch pathway activity. Increased Notch 
activity in the wing can be visualized by the severity of the 
resulting vein phenotypes. Based on the fact that the NTM 
subfragment and APPL contain a -secretase-mediated 
cleavage site, we reasoned that the expression of both re-
porter transgenes under the control of e16E-GAL4 provides 
a sensitive assay for -secretase-dependent processing of 
Notch and APPL. 
 
Expression of the notch- and APPL-based chimeric 
reporters in wings caused loss of wing veins 
To determine whether both the NTM-SV and APPL-SV chi-
meric reporter proteins transduce Notch signaling activity, 
we ectopically overexpressed these transgenes using e16E-
GAL4 (Figs. 3E and 3H). Ectopic expression of NTM-SV61f in 
the posterior compartment of the wing resulted in moderate 
truncations of L4 and L5 veins in females (Fig. 3D). These 
vein truncation phenotypes were not observed in wild-type, 
e16E-GAL4/ +, and NTM-SV61f/ + female wings (Figs. 3A-3C). 
Interestingly, in females expressing APPL-SV85m, we ob-
served severe truncations of L4 and L5 veins (Fig. 3G). How-
ever, vein pattern formation in females heterozygous for the 
APPL-SV85m transgene was normal (Fig. 3F). These findings 
might suggest that both the NTM-SV and APPL-SV reporter 
proteins were processed at least by -secretase, and they 
further demonstrate that the -secretase-cleaved C-terminal 
fragments of both reporters including the SV can transduce 
Notch activity in the wing. 
To further address the difference in phenotypic severity be-
tween NTM-SV and APPL-SV (Figs. 3D and 3G), we obtained 
a total of 5 independent transgenic lines for NTM-SV and a 
total of 4 lines for APPL-SV. On average, ectopic expression 
in 5 different lines for NTM-SV caused 43.1% L4 vein trunca-
tions and 43.8% L5 vein truncations (n = 84), while expres-
sion in 4 different lines for APPL-SV resulted in 90.4% L4 
vein truncations and 96.8% L5 vein truncations (n = 62) (Fig. 
3I). An almost 2-fold difference in the percentage of both 
vein truncations between NTM-SV and APPL-SV (p < 0.001, t-
test; Fig. 3I) strongly suggests that the NTM-SV and APPL-SV 
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Fig. 3. Ectopic expression of Notch- and APPL-based reporters in 
wings results in vein truncations. (A) Wild-type wing shows a 
normal pattern of five longitudinal veins (L1-L5). Scale bar indi-
cates 50 m. (B) Female heterozygous for e16E-GAL4 displays a 
normal vein pattern. (C) Female heterozygous for UAS-NTM-SV61f 
shows a normal vein pattern. (D) Overexpression of NTM-SV61f in 
the posterior compartment leads to moderate vein truncation 
(arrows). (E) The NTM-SV proteins are expressed homogeneously 
in the posterior compartment of the wing imaginal disc. Anterior 
is up. (F) Female heterozygous for UAS-APPL-SV85m shows a 
normal vein pattern. (G) Overexpression of APPL-SV85m in the 
posterior compartment causes severe vein truncation (arrows). 
Asterisks indicate a false vein. (H) Expression pattern of the 
APPL-SV proteins is relatively sparse in the posterior compart-
ment of the wing imaginal disc. Anterior is up. (I) Percentages of 
wing vein truncations in females with indicated genotypes (***p 
< 0.001, t-test). Error bars indicate S.E.M. by t-test. n = number 
of wings scored for each genotype. 
 
 
 
 
proteins are differentially processed by -secretase and/or the 
-secretase-cleaved C-terminal portions of both reporter 
proteins generate different levels of Notch transducing activ-
ity. Another possibility is that the APPL-SV proteins are more 
abundantly expressed than the NTM-SV proteins. 
 
Reporter-mediated wing vein phenotypes are enhanced 
by Notch and suppressed by presenilin 
Based on wing vein phenotypes, we deduced that the NTM-
SV and APPL-SV reporter proteins transduce Notch activity 
(Fig. 3). To further address this issue, we investigated genetic 
interactions among NTM-SV, Notch, and psn. Ectopic expres-
sion of NTM-SV61f in the posterior compartment resulted in 
38.3% L4 vein truncations and 33.6% L5 vein truncations 
(Figs. 4B and 4G). These NTM-SV61f vein phenotypes were 
significantly enhanced by one copy of NAx-E2 allele: from 
38.3% to 69.2% for L4 vein truncations (p < 0.001, t-test) 
 
A           B 
 
  
C           D 
 
  
E           F 
 
 
 
G 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 4. Genetic interactions among NTM-SV61f, Notch, and prese-
nilin alleles. (A) Females heterozygous for e16E-Gal4 show a 
normal pattern of five longitudinal veins. Scale bar indicates 
50 m. (B) Overexpression of NTM-SV61f in the posterior 
compartment results in moderate vein truncation (arrows). 
(C) In females heterozygous for NAx-E2, the wing shows mild 
truncation only in L5 vein (arrow). (D) One copy of NAx-
E2mutation slightly enhances the gain-of-function (GOF) 
phenotype of NTM-SV61f (arrows). (E) Overexpression of psn 
RNAi in the posterior compartment results in vein thickening 
(square brackets). (F) Overexpression of psn RNAi completely 
suppresses the GOF phenotype of NTM-SV61f. Square brack-
ets indicate vein thickening phenotype. (G) Percentages of 
wing vein truncations in females with indicated genotypes 
(**p < 0.01 and ***p < 0.001, t-test). Error bars indicate 
S.E.M. by t-test. n = number of wings scored for each geno-
type. 
 
 
 
and from 33.6% to 41.0% for L5 vein truncations (p = 
0.001, t-test) (Figs. 4C, 4D, and 4G). Similar patterns of ge-
netic interactions were also observed with a different inser-
tion line, NTM-SV42m (p < 0.001, t-test for both veins; Sup-
plementary Figs. S2C, S2D, and S2G). Overexpression of 
NTM-SV42m in the wing led to 57.0% L4 vein truncations and 
57.7% L5 vein truncations, which are greater than those 
obtained after ectopic expression of NTM-SV61f (Supplemen-
tary Figs. S2B and S2G). These findings support the claim 
that the NTM-SV proteins transduce Notch activity in the wing. 
In contrast, the NTM-SV61f and NTM-SV42m vein truncation 
phenotypes were completely suppressed by RNAi-mediated 
knockdown of psn (Figs. 4E-4G and Supplementary Figs.  
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Fig. 5. Genetic interactions among APPL-SV85m, Notch, and pre-
senilin alleles. (A) Females heterozygous for e16E-Gal4 show a 
normal pattern of five longitudinal veins. Scale bar indicates 50 
m. (B) Overexpression of APPL-SV85m in the posterior com-
partment results in severe vein truncation (arrows). Asterisks 
indicate a false vein. (C) In females heterozygous for NAx-E2, the 
wing shows mild truncation only in L5 vein (arrow). (D) One 
copy of NAx-E2mutation slightly enhances the GOF phenotype of 
APPL-SV85m (arrows). (E) Overexpression of psn RNAi in the 
posterior compartment results in vein thickening (square brack-
ets). (F) Overexpression of psn RNAi partly suppresses the GOF 
vein phenotype of NTM-SV61f. (G) Percentages of wing vein trun-
cations in females with indicated genotypes (**p < 0.01 and 
***p < 0.001, t-test). Error bars indicate S.E.M. by t-test. n = 
number of wings scored for each genotype. 
 
 
 
S2E-S2G), indicating that Psn is required for the gain of NTM-
SV function in the wing. Interestingly, the psn RNAi-
mediated vein thickening phenotype was also suppressed, 
but it was not completely suppressed by overexpression in 
either NTM-SV transgenic line (Figs. 4E, 4F, Supplementary 
Figs. S2E and S2F). Therefore, knockdown of psn is epistatic 
to NTM-SV overexpression with respect to vein pattern for-
mation in the wing. 
We next analyzed genetic interactions among APPL-SV, 
Notch, and psn. Females overexpressing APPL-SV85m in the 
posterior compartment showed highly penetrant vein trun-
cation defects: 84.8% L4 vein truncations and 90.0% L5 
vein truncations (Figs. 5B and 5G). These APPL-SV85m vein 
phenotypes were enhanced by one copy of NAx-E2 allele: from 
84.8% to 94.7% for L4 vein truncations (p = 0.001, t-test) 
and from 90.0% to 98.2% for L5 vein truncations (p = 
0.003, t-test), suggesting that the APPL-SV proteins can act 
as a Notch signal transducer in the wing (Figs. 5C, 5D, and 
5G). Similar patterns of genetic interactions for both L4 and 
L5 vein phenotypes were not observed with the APPL-SV82m 
transgene, a different insertion line (p > 0.3, t-test; Supple-
mentary Figs. S3C, S3D, and S3G), probably due to high 
penetrance of vein truncation defects in females overex-
pressing APPL-SV82m alone (92.8% for L4 veins and 100% 
for L5 veins; Supplementary Fig. S3G). In addition, we found 
that the APPL-SV85m vein truncation phenotypes were ro-
bustly suppressed by RNAi-mediated knockdown of psn: 
from 84.8% to 51.2% for L4 vein truncations (p<0.001, t-
test) and from 90.0% to 1.6% for L5 vein truncations (p < 
0.001, t-test) (Figs. 5E-5G). Partial suppression especially in 
L4 veins, which is different from that observed in females 
coexpressing psn RNAi and NTM-SV (Figs. 4F and 4G), might 
indicate that APPL-SV-induced Notch activity antagonizes 
the knockdown effects of psn to a greater extent than NTM-
SV. Furthermore, similar patterns of suppressive genetic in-
teractions were also observed with the APPL-SV82m 
transgene (p < 0.001, t-test for both L4 and L5 vein trunca-
tions; Supplementary Figs. S3E-S3G), demonstrating the 
requirement of Psn for the gain of APPL-SV function in the 
wing. Females coexpressing psn RNAi and APPL-SV exhibit-
ed large reduction in vein thickening phenotype compared 
to females overexpressing psn RNAi alone (Figs. 5E and 5F, 
Supplementary S3E and S3F), which is indicative of the an-
tagonistic relationships between knockdown of psn and 
APPL-SV overexpression in patterning of the wing veins. 
 
The role of apoptosis in reporter-induced wing vein 
truncations 
Since Notch plays a role in apoptosis during Drosophila visual 
system development (Bertet et al., 2014; Brachmann and 
Cagan, 2003), we investigated whether Notch-mediated 
regulation of apoptosis is involved in patterning of the wing 
veins. Interestingly, females overexpressing the baculovirus 
pan-caspase inhibitor p35, which has been shown to pre-
vent apoptotic death in Drosophila (Hay et al., 1994), exhib-
ited a mild phenotype only in L5 vein, indicating a positive, 
but a minor role of apoptosis in vein pattern formation 
(3.5% vein truncation; Figs. 6D and 6G). In females express-
ing both p35 and NTM-SV61f in the posterior compartment, 
we observed a small but significant increase in vein pheno-
types compared to females overexpressing NTM-SV61f: from 
38.3% to 51.1% for L4 vein truncations (p < 0.001, t-test) 
and from 33.6% to 46.1% for L5 vein truncations (p < 
0.001, t-test) (Figs. 6B, 6E and 6G). Similar enhancement in 
vein phenotype was also found in females coexpressing p35 
and NTM-SV42m in the posterior compartment: from 57.0% 
to 60.5% for L4 vein truncations (p = 0.03, t-test) and from 
57.7% to 76.6% for L5 vein truncations (p < 0.001, t-test) 
(Supplementary Figs. S4B, S4E, and S4G). Taken together, 
this seemingly additive genetic interaction between p35 and 
NTM-SV suggests that NTM-SV-induced vein truncation is not 
due to apoptosis. 
To examine whether APPL-SV-induced vein phenotypes re-
sult from apoptosis, we coexpressed p35 and APPL-SV85m in 
the posterior compartment of the wing. Unexpectedly, we 
observed that coexpression of p35 and APPL-SV85m robustly 
suppressed L4 vein truncation phenotypes of APPL-SV85m 
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Fig. 6. Apoptosis partly contributes to vein truncations induced by 
the APPL-based reporter. (A) Females heterozygous for e16E-
Gal4 show a normal pattern of five longitudinal veins. Scale bar 
indicates 50 m. (B) Overexpression of NTM-SV61f in the posterior 
compartment results in moderate vein truncation (arrows). (C) 
Overexpression of APPL-SV85m in the posterior compartment 
leads to severe vein truncation (arrows). Asterisks indicate a false 
vein. (D) Overexpression of p35 in the posterior compartment 
results in slight vein truncation (arrow). (E) Coexpression of 
p35in the posterior compartment slightly increases the GOF vein 
phenotype of NTM-SV61f (arrows). (F) Coexpression of p35in the 
posterior compartment differentially affects the GOF vein phe-
notype of APPL-SV85m (arrows). (G) Percentages of wing vein 
truncations in females with indicated genotypes (**p < 0.01 and 
***p < 0.001, t-test). Error bars indicate S.E.M. by t-test. n = 
number of wings scored for each genotype. 
 
 
 
from 84.8% to 56.8% (p < 0.001, t-test), whereas coex-
pression of p35 and APPL-SV85m enhanced L5 vein trunca-
tion phenotypes from 90.0% to 97.0% (p = 0.003, t-test) 
(Figs. 6C, 6F, and 6G). Suppressive genetic interactions were 
also observed in L4 veins, but not in L5 veins with the APPL-
SV82m transgene: from 92.8% to 54.8% for L4 vein trunca-
tions (p < 0.001, t-test) and no change was observed in L5 
vein truncations (Supplementary Figs. S4C, S4F, and S4G). 
Strong suppressive interactions between p35 and APPL-SV, 
especially in L4 veins suggest that overexpression of APPL-SV 
leads to cell death, and they further demonstrate that APPL-
SV-induced cell death partly contributes to L4 vein trunca-
tion phenotypes. However, phenotypic enhancement ob-
served in L5 veins, which is similar to that observed in fe-
males coexpressing p35 and NTM-SV (Fig. 6G), suggests that 
apoptosis is not attributable to L5 vein truncation pheno-
types of APPL-SV. 
DISCUSSION 
 
Drosophila melanogaster provides a powerful genetic tool to 
analyze gene function associated with human diseases in-
cluding Alzheimer’s disease (AD) and evolutionarily con-
served signaling pathways (Bier, 2005; Lu and Vogel, 2009). 
Indeed, many different Drosophila models of AD, which 
showed progressive degeneration through elevated produc-
tion of amyloid -peptides (As), were developed (Fernan-
dez-Funez et al., 2015). Some of these AD models are based 
on overexpression of wild-type human APP, EOAD-
associated mutant APP, or a secreted form of human A42 
peptide (Fernandez-Funez et al., 2015). These findings 
demonstrate highly conserved mechanisms underlying A-
mediated neurotoxicity and neurodegeneration between 
Drosophila and humans. This is further supported by the fact 
that the fly genome contains functional homologs for most 
of the EOAD-associated genes including APP, PS1, and PS2 
(Martin-Morris and White, 1990; Stempfle et al., 2010). In 
combination with human BACE, Drosophila -secretase is 
able to cleave human APP to generate Apeptides, indicat-
ing its conserved intramembrane proteolytic activity (Greeve 
et al., 2004). Although the A sequence is not well con-
served among APP homologs from different species, a 
growing body of evidence suggests that all APP homologs 
play an important and conserved role in neural development 
including neurite growth, axon guidance, and synaptogene-
sis (Nicolas and Hassan, 2014). However, little is known 
about how -secretase-mediated proteolytic processing of 
APP is regulated at the molecular and genetic levels. 
One of the hallmarks of AD is senile plaques largely con-
sisting of As, which are produced by sequential cleavages 
of APP by -secretase (BACE) and -secretase (Esler and 
Wolfe, 2001; Goedert, 2015). Given that all known muta-
tions responsible for early-onset familial Alzheimer’s disease 
(EOAD) are localized in APP, PS1, and PS2 (Tanzi, 2012), -
secretase represents a good therapeutic target for develop-
ing A-lowering drugs. Therefore, brain-penetrant inhibitors 
of -secretase are emerging as one of the most effective 
therapies for AD (De Strooper et al., 2010). However, toxici-
ty of -secretase inhibitors was found to be a major hurdle in 
preclinical studies since -secretase is also required for the RIP 
of numerous other substrates including Notch (De Strooper 
et al., 2010; Esler and Wolfe, 2001; McCarthy et al., 2009). 
Here, as an alternative approach to overcome this target-
based toxicity, we report the development of a Drosophila 
reporter system for in vivo detection of -secretase activity. 
Based on several observations, we expect that this in vivo 
reporter system will provide a genetic tool to discover novel 
genes, which specifically modulate -secretase-mediated 
processing of Notch and APPL. First, overexpression of the 
NTM-SV reporter proteins in the wing induced vein truncation 
phenotypes that are totally dependent on -secretase activity. 
Second, not only -secretase activity, but also apoptosis con-
tributes to the vein truncation phenotypes of the APPL-SV 
reporter transgene. This appears to be consistent with previ-
ous observations suggesting that human APP induces APP 
intracellular domain (AICD)-dependent cell death in Dro-
sophila (Gunawardena and Goldstein, 2001; Wang et al., 
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2014). Since the -secretase-cleaved C-terminal fragment of 
APPL-SV contains the APPL intracellular domain (dAICD) in 
addition to the SV, dAICD might be responsible for the con-
tribution of apoptosis. Third, both NTM-SV and APPL-SV 
transduce Notch signaling activity in a dose-dependent 
manner. In support of this claim, reporter-induced vein phe-
notypes are enhanced by one copy of NAx-E2, which is a 
Notch GOF allele. Fourth, APPL-SV-induced phenotype is 
almost 2-fold greater than the GOF phenotype of NTM-SV, 
probably due to differences in their RIP and the contribution 
of dAICD-dependent apoptosis. 
Several -secretase associated proteins (GSAPs), in addition 
to the four main components of the -secretase complex, 
have been discovered (Chen et al., 2006; He et al., 2010; 
Teranishi et al., 2015; Wakabayashi et al., 2009; Zhou et al., 
2005). These GSAP proteins, including TMP21, pigeon 
homologue protein, and proton myo-inositol cotransporter, 
regulate substrate selectivity and A production. Therefore, 
these GSAPs can serve as therapeutic targets for the treat-
ment of AD. These observations might indicate the existence 
of unknown GSAP proteins regulating A production with-
out affecting proteolytic cleavage of other -secretase sub-
strates including Notch. Future work using the in vivo re-
porter system developed in this study will determine whether 
known and additional unknown GSAP proteins are required 
for modulation of -secretase activity, and how substrate 
specificity of -secretase is regulated. Our current reporter 
system can also be applied to screening of chemical com-
pound libraries. 
 
Note: Supplementary information is available on the Mole-
cules and Cells website (www.molcells.org). 
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